Global Leading Market Research Publisher QYResearch announces the release of its latest report “Oligonucleotide Purification – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032”. Based on current situation and impact historical analysis (2021-2025) and forecast calculations (2026-2032), this report provides a comprehensive analysis of the global Oligonucleotide Purification market, including market size, share, demand, industry development status, and forecasts for the next few years.
For biopharmaceutical executives, research directors, and quality assurance managers in the life sciences, the promise of nucleic acid-based technologies hinges on one critical factor: purity. Synthesized oligonucleotides—short strands of DNA or RNA—are the fundamental building blocks for a revolution in medicine, diagnostics, and research. However, the chemical synthesis process inevitably generates truncated sequences, residual reagents, and other impurities. If left unpurified, these contaminants can lead to failed experiments, inaccurate diagnostic results, or, in the case of therapeutics, potentially harmful side effects and lack of efficacy. The solution lies in specialized oligonucleotide purification services, which employ advanced techniques like high-performance liquid chromatography (HPLC) , gel electrophoresis, and other chromatographic methods to isolate the desired full-length product with extremely high precision. According to QYResearch’s baseline data, the global market for these essential services was estimated to be worth US$ 271 million in 2024. Driven by the explosive growth of genomics, the clinical success of nucleic acid-based drugs, and the expansion of personalized medicine, it is forecast to achieve a readjusted size of US$ 382 million by 2031, reflecting a steady CAGR of 5.2% during the forecast period.
[Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)]
(https://www.qyresearch.com/reports/4705589/oligonucleotide-purification)
The Technology Defined: Ensuring Purity for Precision Biology
Oligonucleotide purification is a specialized set of processes designed to separate the desired, full-length oligonucleotide from the complex mixture resulting from solid-phase chemical synthesis. The choice of purification method depends on the length of the oligonucleotide, the required purity level, and the intended application.
The QYResearch report segments the market by these key purification technologies:
- HPLC Oligo Purification: High-performance liquid chromatography (HPLC) , particularly ion-pair reversed-phase HPLC, is the gold standard for achieving the highest purity levels, often exceeding 90-95%. It separates oligonucleotides based on their hydrophobicity, effectively removing truncated sequences (failure products) that are even one nucleotide shorter or longer than the target. This method is essential for therapeutic oligonucleotide manufacturing and for sensitive molecular diagnostic reagents where absolute precision is paramount.
- PAGE Oligo Purification: Polyacrylamide gel electrophoresis (PAGE) separates oligonucleotides by size. A polyacrylamide gel is used as a molecular sieve, with smaller fragments migrating faster than larger ones. The band corresponding to the full-length product is then excised from the gel and eluted. PAGE offers very high resolution and is often used for longer oligonucleotides (e.g., >50-60mers) and for research applications where very high purity is required, though it is more labor-intensive and lower throughput than HPLC.
- Reversed-Phase Cartridge Purification: This is a simpler, faster, and more cost-effective method, often used for standard research primers and probes where ultra-high purity is not critical. It relies on hydrophobic interactions to retain the desired oligonucleotide while washing away shorter, more hydrophilic failure sequences. It provides a significant improvement over crude desalting but does not achieve the same resolution as HPLC or PAGE.
- Other: This category includes emerging or specialized techniques, such as desalting (the most basic purification) and affinity-based methods for modified oligonucleotides.
Key Market Drivers: The Convergence of Research, Diagnostics, and Therapy
The projected 5.2% CAGR for the oligonucleotide purification market is underpinned by powerful, synergistic trends across the life science landscape.
1. The Explosion of Nucleic Acid-Based Therapeutics:
The clinical and commercial success of mRNA vaccines for COVID-19 has validated the power of nucleic acid technologies. This has unleashed a torrent of investment and development in other oligonucleotide therapeutics, including antisense oligonucleotides (ASOs), siRNAs, and aptamers for a wide range of diseases, from rare genetic disorders to common conditions like hypertension and cancer. These nucleic acid-based drugs require unprecedented levels of purity and consistency to meet the stringent safety and efficacy standards of regulatory agencies like the FDA and EMA. This demand is the primary driver for high-end purification services, particularly HPLC, in the pharmaceutical production segment.
2. The Growth of Molecular Diagnostics and Personalized Medicine:
Oligonucleotides are the workhorses of molecular diagnostics, serving as primers and probes in techniques like PCR and next-generation sequencing (NGS). These applications require highly specific and consistent reagents to ensure accurate and reproducible results. Impure oligonucleotides can lead to false positives, false negatives, and inconsistent assay performance, which is unacceptable in clinical settings. The global expansion of molecular testing for infectious diseases, cancer biomarkers, and genetic predispositions directly fuels the demand for high-quality, purified molecular diagnostic reagents.
3. Advancements in Genomics and Gene Synthesis:
Basic research and the rapidly growing field of synthetic biology rely on the ability to synthesize and assemble long, complex DNA sequences. Gene synthesis, which involves piecing together many oligonucleotides, requires each individual component to be of high purity to ensure the final assembled gene is correct. The push for longer and more complex synthetic constructs drives the need for high-resolution purification methods like PAGE and HPLC in the scientific research sector.
The Competitive Landscape: A Diverse Mix of Specialists and Global Life Science Leaders
The oligonucleotide purification market is served by a dynamic mix of global life science tool providers, specialized oligonucleotide manufacturers, and contract research organizations (CROs).
- Global Life Science Giants: Companies like Thermo Fisher, Agilent, and Cytiva are dominant forces, providing both the instrumentation (HPLC systems, chromatography media) and, in many cases, offering purification as a service or as part of their custom oligonucleotide synthesis platforms. Their vast resources and global reach make them key players.
- Specialized Oligonucleotide and Gene Synthesis Companies: GENEWIZ (Azenta Life Sciences), Genscript, and Eurogentec are leading providers of custom oligonucleotides and gene synthesis services, with in-house purification expertise. They serve the full spectrum of academic, biotech, and pharma customers.
- Biosearch Technologies is another specialist known for its expertise in oligonucleotide probes and primers.
- Emerging and Regional Players: The list includes a significant number of companies from China, such as SUZHOU NANOMICRO TECHNOLOGY, Asymchem, GentleGen, and Beijing Tsingke Biotech. This reflects the rapid growth of China’s life science research and biopharmaceutical sectors, with local companies building advanced capabilities in oligonucleotide synthesis and purification to serve the domestic and global markets.
- Oligo Factory and IntegrateRNA are examples of specialized suppliers focusing on custom oligonucleotide synthesis, including various purification options.
For all players, success hinges on technological expertise, the ability to scale from research-grade to GMP-grade purity, and reliable service. The 5.2% CAGR forecast by QYResearch signals a healthy, growing market essential to the advancement of modern biology and medicine.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666(US)
